Ending a lawsuit initiated by US pharmaceutical company Merck&Co, the higher court in Ljubljana has ruled in favour of Slovenian pharmaceutical company Krka, dismissing Merck’s claim that Krka was infringing its patent in the production of a generic drug called Enalapril. According to Bluebull, the ruling is final, and now Merck’s only recourse is through extraordinary appeal....


This story is part of New Europe's Premium content.

To Read the Full Story, Subscribe or Sign In from the ↑ Top of the Page ↑
new europe join now